To investigate the anti-inflammatory mechanism of CAPE in ETBF colitis-promoted tumorigenesis, we employed the human colonic carcinoma cell line HT29/C1 to examine BFT-induced inflammatory signaling. The gene discussed is SMC2; the disease is colitis.